Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.

Nicholls SJ, Gordon A, Johansson J, Wolski K, Ballantyne CM, Kastelein JJ, Taylor A, Borgman M, Nissen SE.

J Am Coll Cardiol. 2011 Mar 1;57(9):1111-9. doi: 10.1016/j.jacc.2010.11.015. Epub 2011 Jan 20.

2.

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.

Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJ, Hutten BA.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1803-10. Epub 2007 Jun 14. Review.

3.

Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?

Seshasai SR, Ray KK.

Future Cardiol. 2009 Mar;5(2):129-39. doi: 10.2217/14796678.5.2.129. Review.

PMID:
19371188
4.

The intensive statin therapy myth.

Shechter M, Beigel R, Matetzky S, Freimark D, Chouraqui P.

Isr Med Assoc J. 2005 Nov;7(11):683-7. Review.

5.

Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.

Davidson MH, Ose L, Frohlich J, Scott RS, Dujovne CA, Escobar ID, Bertolami MC, Cihon F, Maccubbin DL, Mercuri M.

Clin Cardiol. 2003 Nov;26(11):509-14. Review.

6.

[Apolipoprotein A-I].

Sasaki J.

Nihon Rinsho. 1999 Sep;57 Suppl:87-9. Review. Japanese. No abstract available.

PMID:
10543056

Supplemental Content

Support Center